A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal.


Journal

The new microbiologica
ISSN: 1121-7138
Titre abrégé: New Microbiol
Pays: Italy
ID NLM: 9516291

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 10 09 2019
accepted: 10 09 2019
pubmed: 4 6 2019
medline: 21 9 2019
entrez: 4 6 2019
Statut: ppublish

Résumé

IgM-enriched immunoglobulins (e-IgM) may be useful in patients with severe acute bacterial infections. The evidence for the administration of e-IgM is not extensive and a definitive consensus has never been reached on its best use in patients with acute infections as well as in critically ill patients. However, the official indication in several countries, including Italy, is quite wide and mainly refers to supportive treatment of patients with acute severe bacterial infections. A multidisciplinary meeting of Italian Experts in Infectious Diseases, Anesthesia and Critical Care, Pneumology, Microbiology and Oncohaematology aimed to produce a statement on the best practical methodological score that could improve the use of e-IgM in patients with different infections, variable severity of disease and etiology. The Expert Panel reviewed the literature and the available guidelines, discussed the experience and eventually proposed to adapt the PIRO score to the practical methodological needs of a simple tool that could guide the administration of e-IgM.

Identifiants

pubmed: 31157400
pii: 496N087

Substances chimiques

Immunoglobulin M 0
Immunoglobulins, Intravenous 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-180

Auteurs

Francesco Giuseppe De Rosa (FG)

Department of Medical Sciences, Infectious Diseases, University of Turin, Italy.

Silvia Corcione (S)

Department of Medical Sciences, Infectious Diseases, University of Turin, Italy.

Carlo Tascini (C)

First Division of Infectious diseases, Cotugno Hospital, Naples, Italy.

Daniela Pasero (D)

Department of Anesthesia and Intensive Care, A.O.U. Città della Salute e della Scienza, Turin, Italy.

Andrea Rocchetti (A)

Laboratory of Microbiology, SS Antonio, Biagio and C. Arrigo Hospital, Alessandria, Italy.

Massimo Massaia (M)

Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Italy.

Giorgio Berlot (G)

Department of Anesthesia, Resuscitation and Pain Therapy, Cattinara Hospital, University of Trieste, Italy.

Paolo Solidoro (P)

SCDU of Pneumology, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, University of Turin, Italy.

Massimo Girardis (M)

Anesthesia and Intensive Care Unit, University Hospital of Modena, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH